Quality of life assessment in patients with cystic fibrosis by means of the Cystic Fibrosis Questionnaire

J Bras Pneumol. 2011 Mar-Apr;37(2):184-92. doi: 10.1590/s1806-37132011000200008.
[Article in English, Portuguese]

Abstract

Objective: To assess the quality of life (QoL) of patients with cystic fibrosis (CF) followed at a university referral center for CF.

Methods: A cross-sectional study involving application of the Cystic Fibrosis Questionnaire (CFQ) and Shwachman score in CF patients between April of 2008 and June of 2009.

Results: The sample consisted of 75 patients. The mean age was 12.5 ± 5.1 years (range, 6.1-26.4 years). The patients were divided into three groups by age in years: group I (< 12), II (12-14), and III (> 14). The highest and lowest CFQ scores were for the nutrition domain in group III (89.3 ± 16.2) and the social domain in group II (59.5 ± 22.3), respectively. Groups I and III differed significantly regarding the treatment domain (p = 0.001). Regarding Shwachman scores, there were significant differences between patients scoring < 70 and those scoring > 70 in the social (group I; p = 0.045), respiratory (group II; p = 0.053), and digestive (p = 0.042) domains. In group III, severity did not correlate with QoL. In groups I and II, patients with an FEV1 < 80% of predicted did not differ from other patients for any CFQ domain. However, in group III, values for the following domains were significantly lower in patients with an FEV1 < 80%: physical (p = 0.012); body image (p = 0.031); respiratory (p = 0.023), emotional (p = 0.041); and social role (p = 0.024).

Conclusions: It is important to assess QoL in CF patients, because it can improve treatment compliance.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cross-Sectional Studies
  • Cystic Fibrosis / physiopathology*
  • Female
  • Humans
  • Male
  • Quality of Life*
  • Severity of Illness Index
  • Statistics, Nonparametric
  • Surveys and Questionnaires*
  • Young Adult